Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
槟藿痛风合剂 (Binghuo Gout Compound) is a proprietary traditional Chinese medicine (TCM) oral liquid formulation developed and manufactured by Sichuan Sunnyhope Pharmaceutical. It is indicated for the treatment of gout and is recognized as an exclusive TCM variety in China. The preparation is part of the company's core product line, which focuses on gout specialty drugs and essential medicines. As a TCM mixture (Heji), it utilizes a combination of herbal ingredients to manage gout symptoms and potentially regulate uric acid levels through multi-target anti-inflammatory and metabolic pathways common in traditional herbal medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Binghuo Gout Compound.